Phase 3 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You weigh at least 10 kg (about 22 pounds) at the time of screening and at the start of the trial.
- You have been diagnosed with moderate to severe Crohn's Disease in children or teens, confirmed by specific activity scores and a camera examination of the gut (colonoscopy) showing inflammation.
- Your Crohn's Disease diagnosis has been confirmed by colonoscopy during the screening period, with biopsy results supporting the diagnosis, and with no signs of current infection or abnormal/cancerous cells in the colon.
- Previous treatments (such as steroids, immune-suppressing medicines, or biologic therapies) have not worked well enough for you, stopped working, caused intolerance, or cannot be used for medical reasons. (Note: if you are in the US or South Korea, you must specifically have had an inadequate response, loss of response, or intolerance to at least one anti-TNF biologic medication.)
Who may not be able to join:
- You were first diagnosed with Crohn's Disease before the age of 2.
- You currently have an active abscess (a pocket of infection) in the abdomen or around the back passage.
- You currently have bowel blockages causing symptoms.
- More than 2 out of 5 specific sections of your intestine are missing.
- You have a stoma (ostomy bag) or an internal pouch connected to your bowel.
- You have had bowel surgery in the last 3 months, or more than 3 bowel surgeries in total.
- You are participating in Japan and have a positive or repeatedly unclear test result for a specific fungal infection screening (confirm with trial site).
- You currently have ulcerative colitis, indeterminate colitis, or a rare inherited form of inflammatory bowel disease.
- You have a history of a severe, rapidly worsening bowel condition called fulminant colitis or toxic megacolon.
- You have had a hole (perforation) develop in your gut (unless caused by appendicitis or a physical injury), a history of diverticulitis, or other conditions that significantly raise the risk of gut perforation, such as a history of the bowel twisting or telescoping.
- You currently have any condition where your immune system does not work properly from birth (primary immune deficiency).
- You have a condition that affects how your body absorbs medicines, such as short bowel syndrome or a history of gastric bypass surgery. (Note: a history of gastric banding alone does not exclude you — confirm with trial site.)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: ABBVIE INC., AbbVie
Phone: 844-663-3742
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
5 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Percentage of participants who achieved clinical response per the Pediatric Crohn's Disease Activity Index (PCDAI) at Week 12, with clinical remission per the PCDAI at Week 64; Achievement of endoscopic response at Week 64 in participants who achieved clinical response per PCDAI at Week 12.; Number of Participants with Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.